直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Anti-SLAPP Confers Jurisdiction for Interlocutory Appeals

November 5, 2025

Authored and Edited by Jillian M. Baggett; Wyatt L. Bazrod; Erik R. Puknys

In IQE PLC. v. Newport Fab, LLC, No. 2024-1124 (Fed. Cir. Oct. 15, 2025), the Federal Circuit vacated a district court decision denying defendant’s Anti-SLAPP motion.

The parties, IQE and Tower, previously negotiated for Tower to use IQE’s wafers in its semiconductor products. After negotiations fell through, IQE sued Tower for trade-secret violations, contending that it disclosed IQE’s confidential information in patent applications that were filed during (and shortly after) the parties’ negotiations. Tower moved to invoke California’s anti-SLAPP statute in response, arguing that filing for patent applications was an exercise of its constitutional right to petition the government. The district court denied the motion.

As an issue of first impression, the Federal Circuit first assessed whether it had jurisdiction over an interlocutory appeal from a district court’s denial of an anti-SLAPP motion to strike. Applying the “collateral order” three-factor test, the Federal Circuit held that it had jurisdiction, explaining that if Tower could not immediately appeal the order, the protection of the act would be irretrievably lost because Tower would have already incurred the burden of litigation by the time a final judgment was rendered.

After assessing jurisdiction, the Federal Circuit concluded that the district court improperly applied the Ninth Circuit’s anti-SLAPP two-step inquiry. Specifically, step one requires identifying the “protected activity,” which the district court framed as the possession of allegedly secret material. The Federal Circuit instead found that the correct question was whether the submission of that material in the patent applications was protected activity under the Anti-SLAPP statute. The Court concluded it was and remanded to the district court for further consideration of Tower’s motion.

Tags

jurisdiction

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Related Industries

AI, Electronics, and Information Technology

Electronic Devices and Components

Related Offices

Atlanta, GA

Palo Alto, CA

Contacts

Jillian M. Baggett
Associate
Atlanta, GA
+1 404 653 6441
Email
Wyatt L. Bazrod
Associate
Atlanta, GA
+1 404 653 6518
Email
Erik R. Puknys
Partner
Palo Alto, CA
+1 650 849 6644
Email

Copyright © 2025 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

IP Life Sciences Forum 2026

December 13-15, 2026

Coral Gables

Conference

IAM Live: Trade Secret Strategy USA

November 10, 2026

San Jose

Conference

2026 TIPA International Symposium

October 30, 2026

Taipei City

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Lecture

2026 Donald R. Dunner Endowed Lecture

October 27, 2026

Washington, DC

Hybrid Seminar

Annual Intellectual Property Law Section Fall Seminar

October 16, 2026

Alexandria

Webinar

2026 Inventive Step in Europe and the US: Comparing the UPC, EPO and National Approaches

October 14, 2026

Webinar

Conference

2nd Annual Forum on Pharma & Biotech Patent Litigation USA & Canada

October 14-16, 2026

New York

Conference

WTR Live: Brand Strategy Summit USA 2026

October 13-14, 2026

New York

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP